These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2256110)

  • 21. Monokine-induced lung injury in rats: similarities to monocrotaline-induced pneumotoxicity.
    Gillespie MN; Olson JW; Hennig B; Cohen DA; McClain CJ; Goldblum SE
    Toxicol Appl Pharmacol; 1989 Mar; 98(1):134-43. PubMed ID: 2494779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyamine synthesis blockade in monocrotaline-induced pneumotoxicity.
    Olson JW; Orlinska U; Gillespie MN
    Biochem Pharmacol; 1989 Sep; 38(17):2903-10. PubMed ID: 2505777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    Ganey PE; Sprugel KH; Hadley KB; Roth RA
    J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 1 bioactivity in the lungs of rats with monocrotaline-induced pulmonary hypertension.
    Gillespie MN; Goldblum SE; Cohen DA; McClain CJ
    Proc Soc Exp Biol Med; 1988 Jan; 187(1):26-32. PubMed ID: 3124119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
    Schultze AE; Roth RA
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):129-37. PubMed ID: 7687795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 6-keto prostaglandin F1 alpha and thromboxane B2 in isolated, buffer-perfused lungs from monocrotaline pyrrole-treated rats.
    Ganey PE; Roth RA
    Exp Lung Res; 1987; 12(3):195-206. PubMed ID: 3107969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.
    Reindel JF; Roth RA
    Am J Pathol; 1991 Mar; 138(3):707-19. PubMed ID: 2000943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
    Kay JM; Keane PM; Suyama KL; Gauthier D
    Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
    Shubat PJ; Hubbard AK; Huxtable RJ
    J Toxicol Environ Health; 1989; 28(4):445-60. PubMed ID: 2531804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole.
    Ganey PE; Roth RA
    Am J Physiol; 1987 Apr; 252(4 Pt 2):H743-8. PubMed ID: 2952022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
    Ganey PE; Roth RA
    Toxicol Appl Pharmacol; 1987 Apr; 88(2):157-64. PubMed ID: 3564035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung injury from intratracheal and inhalation exposures to residual oil fly ash in a rat model of monocrotaline-induced pulmonary hypertension.
    Kodavanti UP; Jackson MC; Ledbetter AD; Richards JR; Gardner SY; Watkinson WP; Campen MJ; Costa DL
    J Toxicol Environ Health A; 1999 Aug; 57(8):543-63. PubMed ID: 10515573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole.
    Hilliker KS; Roth RA
    Am Rev Respir Dis; 1985 Jan; 131(1):46-50. PubMed ID: 3966714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats.
    Ilkiw R; Todorovich-Hunter L; Maruyama K; Shin J; Rabinovitch M
    Circ Res; 1989 Apr; 64(4):814-25. PubMed ID: 2495195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocrotaline pyrrole-induced pulmonary hypertension in fawn-hooded rats with platelet storage pool deficiency: 5-hydroxytryptamine uptake by isolated, perfused lungs.
    Hilliker KS; Bell TG; Roth RA
    Thromb Haemost; 1983 Dec; 50(4):844-7. PubMed ID: 6665765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 6-Ketoprostaglandin F1 alpha and thromboxane B2 in isolated, blood-perfused lungs from monocrotaline pyrrole-treated rats.
    Ganey PE; Roth RA
    J Toxicol Environ Health; 1988; 23(1):127-37. PubMed ID: 3336057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelets and the puzzles of pulmonary pyrrolizidine poisoning.
    Roth RA; Ganey PE
    Toxicol Appl Pharmacol; 1988 May; 93(3):463-71. PubMed ID: 3130680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procoagulant and fibrinolytic properties of bovine endothelial cells treated with monocrotaline pyrrole.
    Schultze AE; Roth RA
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):7-15. PubMed ID: 8378934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monocrotaline-induced cardiopulmonary damage in rats: amelioration by the angiotensin-converting enzyme inhibitor CL242817.
    Molteni A; Ward WF; Ts'ao CH; Solliday NH
    Proc Soc Exp Biol Med; 1986 Sep; 182(4):483-93. PubMed ID: 3016747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ventilatory dysfunction precedes pulmonary vascular changes in monocrotaline-treated rats.
    Lai YL; Olson JW; Gillespie MN
    J Appl Physiol (1985); 1991 Feb; 70(2):561-6. PubMed ID: 1902454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.